Contracts › 75A50124C00049
75A50124C00049: Next Gen Recombinant Polyclonal Antibody Discovery Platform for the Develpment of Medical Countermeasures
Awarded to Gigagen Inc by Office of Assistant Secretary for Preparedness and Response.
$29.6Mobligated
$125.6Mpotential value
30 November 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50124C00049 |
|---|---|
| Awardee | Gigagen Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | Q701 Specialized Medical Support |
| Place of performance | CA |
| Offers received | 1 |
| Period of performance | 25 September 2024 to 30 November 2028 |
| Potential end | 23 December 2030 |
| Estimated recompete solicitation | ~Q2 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record